About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
Procedure for reviewingReviewers 2023-2024
About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
Procedure for reviewingReviewers 2023-2024
Logout
Obstetrics and Gynegology2024№8
Moisturizers in the management of...

Moisturizers in the management of patients with complaints of dryness in the genital area

DOI
https://dx.doi.org/10.18565/aig.2024.198

Chernova N.I., Dolya O.V., Frigo N.V., Zadorozhnaya I.S.

Moscow Scientific and Practical Center for Dermatovenerology and Cosmetology, Moscow Healthcare Department, Moscow, Russia

Background: Dryness in the genital area is a common problem that is also relevant for women of reproductive age. It can lead to a number of complications and seriously affect quality of life.
Objective. To present the experience of prescribing suppositories containing hyaluronic acid in combination with lactic acid to women of reproductive age complaining of vaginal dryness and discomfort.
Materials and methods: The observational study included 17 women aged from 22 to 47 years with complaints of sensations of dryness and discomfort in the vaginal area without signs of sexually transmitted infections, not pregnant and not in a state of lactation. In order to control unpleasant symptoms, the patients used vaginal suppositories containing high molecular hyaluronic acid and lactic acid racemate, 10 mg and 5 mg, respectively (Moistana medical product) once a night for a period of 14–18 days. During the follow-up period, the severity of the complaints was evaluated using a visual analog scale, while the severity of the sexual dysfunction was assessed with the Female Sexual Function Index (FSFI) at the baseline and at the follow-up visits, which were conducted on days 8 and 20 from the start of therapy.
Results: At the first control visit, the average value of the "dryness" indicator – M (SD) – decreased from 4.7 (2.08) to 2.4 (1.12) points, and the "itch" indicator – from 3.9 (1.95) to 1.5 (1.23) points. Only 4 of the 17 participants had scores of "dryness" and "itching" indicators exceeding 3 points, being in the range of average severity only, respectively. At the final visit, all women noted an improvement in their condition: the average severity of the complaint "dryness" reached 0.5 (0.3) points, and the complaint "itching" – 0.72 (0.47) points, while 10 of the 17 participants reported complete relief of subjective complaints of dryness and itching in the vagina. The mean FSFI value reached 28.7 (1.9) points by the final visit (vs. 25.7 (2.5) points at baseline), the most marked improvement was observed in the parameters of lubrication (3.6 (0.5) and 4.8 (0.4) points at baseline and at the final visit, respectively) and absence of pain (3.7 (1.2) and 4.9 (0.7) points), and in the satisfaction index.  
Conclusion: Our experience has confirmed that high molecular weight hyaluronic acid is an effective and widely studied moisturizing component in products for the treatment of vulvovaginal dryness. Its combined use together with lactic acid in the form of vaginal suppositories may contribute to a more stable therapeutic result and improve the quality of life of women, including reproductive-aged ones.

Authors’ contributions: Chernova N.I., Dolya O.V., Frigo N.V., Zadorozhnaya I.S. – developing the concept and design of the article; Chernova N.I., Zadorozhnaya I.S. – preparing the material, writing the text; Chernova N.I., Dolya O.V., Frigo N.V. – editing the article.
Conflicts of interest: Authors declare lack of the possible conflicts of interest.
Funding: The study was conducted without sponsorship.
Patient Consent for Publication: The patients provided an informed consent for the publication of their data.
Authors' Data Sharing Statement: The data supporting the findings of this study are available on request from the corresponding author after approval from the principal investigator.
For citation: Chernova N.I., Dolya O.V., Frigo N.V., Zadorozhnaya I.S. Moisturizers 
in the management of  patients with complaints of dryness in the genital area.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2024; (8): 134-140 (in Russian)
https://dx.doi.org/10.18565/aig.2024.198

Keywords

vaginal dryness
discomfort and itching in the vagina
high molecular hyaluronic acid
lactic acid
vaginal suppositories
moistening of the vaginal mucosa
chemotherapy
breast cancer
vulvovaginal dryness
Full text (in Russian)

References

  1. Nappi R.E., Palacios S., Bruyniks N., Particco M., Panay N.; EVES Study investigators. The burden of vulvovaginal atrophy on women's daily living: implications on quality of life from a face-to-face real-life survey. Menopause. 2019; 26(5): 485-91. https://dx.doi.org/10.1097/GME.0000000000001260.
  2. Nappi R.E., Kokot-Kierepa M. Vaginal health: Insights, Views & Attitudes (VIVA) - results from an international survey. Climacteric. 2012; 15(1): 36-44. https://dx.doi.org/10.3109/13697137.2011.647840.
  3. Khani S., Azizi M., Elyasi F., Kamali M., Moosazadeh M. The prevalence of sexual dysfunction in the different menopausal stages: a systematic review and meta-analysis. Int. J. Sex. Health. 2021; 33(3): 439-72. https://dx.doi.org/10.1080/19317611.2021.1926039.
  4. Mijaljica D., Spada F, Harrison I.P. Skin cleansing without or with compromise: soaps and syndets. Molecules. 2022; 27(6): 2010. https://dx.doi.org/10.3390/molecules27062010.
  5. Han J.H., Kim H.S. Skin deep: the potential of microbiome cosmetics. J. Microbiol. 2024; 62(3): 181-99. https://dx.doi.org/10.1007/s12275-024-00128-x.
  6. Mim M.F., Sikder M.H., Chowdhury M.Z.H., Bhuiyan A.U., Zinan N., Islam S.M.N. The dynamic relationship between skin microbiomes and personal care products: A comprehensive review. Heliyon. 2024; 10(14):e34549. https://dx.doi.org/10.1016/j.heliyon.2024.e34549.
  7. Hung K.J., Hudson P.L., Bergerat A., Hesham H., Choksi N., Mitchell C. Effect of commercial vaginal products on the growth of uropathogenic and commensal vaginal bacteria. Sci. Rep. 2020; 10(1): 7625. https://dx.doi.org/10.1038/s41598-020-63652-x.
  8. Lukić M., Pantelić I., Savić S. Towards optimal pH of the skin and topical formulations: from the current state of the art to tailored products. Cosmetics. 2021; 8(3): 69. https://dx.doi.org/10.3390/cosmetics8030069.
  9. Corazza M., Schettini N., Zedde P., Borghi A. Vulvar lichen sclerosus from pathophysiology to therapeutic approaches: evidence and prospects. Biomedicines. 2021; 9(8): 950. https://doi.org/10.3390/biomedicines9080950.
  10. Чернова Н.И., Задорожная И.С. Современные направления в терапии склеротического лишая вульвы. Вопросы гинекологии, акушерства и перинатологии. 2021; 20(4): 142-8. [Chernova N.I., Zadorozhnaya I.S. Current trends in the treatment of vulvar lichen sclerosus. Gynecology, Obstetrics and Perinatology. 2021; 20(4): 142-8. (in Russian)]. https://dx.doi.org/10.20953/1726-1678-2021-4-142-148.
  11. Li T., Ma Y., Zhang H., Yan P., Huo L., Hu Y. et al. Estrogen replacement regulates vaginal innervations in ovariectomized adult virgin rats: a histological study. Biomed. Res. Int. 2017; 2017: 7456853. https://dx.doi.org/10.1155/2017/7456853.
  12. Ito K., Takamatsu K., Nohno K., Sugano A., Funayama S., Katsura K. et al. Factors associated with mucosal dryness in multiple regions and skin: A web-based study in women. J. Obstet. Gynaecol. Res. 2017; 43(5): 880-6. https://dx.doi.org/10.1111/jog.13290.
  13. Kachnic L.A., Bruner D.W., Qureshi M.M., Russo G.A. Perceptions and practices regarding women's vaginal health following radiation therapy: a survey of radiation oncologists practicing in the United States. Pract. Radiat. Oncol. 2017; 7(5): 356-63. https://dx.doi.org/10.1016/j.prro.2017.02.003.
  14. Чернова Н.И., Задорожная И.С., Проскурина М.И. Интимная гигиена у пациенток с зудом и сухостью половых органов. Акушерство и гинекология. 2023; 12: 190-6. [Chernova N.I., Zadorozhnaya I.S., Proskurina M.I. Intimate hygiene in patients with genital itching and dryness. Obstetrics and Gynecology. 2023; (12): 190-6. (in Russian)]. https://dx.doi.org/10.18565/aig.2023.285.
  15. Keen M.A. Hyaluronic acid in dermatology. Skinmed. 2017; 15(6): 441-8.
  16. Potter N., Panay N. Vaginal lubricants and moisturizers: a review into use, efficacy, and safety. Climacteric. 2021; 24(1): 19-24. https://dx.doi.org/10.1080/13697137.2020.1820478.
  17. Donders G., Ruban K., Bellen G., Grinceviciene S. Pharmacotherapy for the treatment of vaginal atrophy. Expert Opin. Pharmacother. 2019; 20(7): 821-35. https://dx.doi.org/10.1080/14656566.2019.1574752.
  18. Nappi R.E., Martella S., Albani F., Cassani C., Martini E., Landoni F. Hyaluronic acid: a valid therapeutic option for early management of genitourinary syndrome of menopause in cancer survivors? Healthcare (Basel). 2022; 10(8): 1528. https://dx.doi.org/10.3390/healthcare10081528.
  19. Patterson J., Millheiser L., Krychman M.L. Moisturizers, lubricants, and vulvar hygiene products: issues, answers, and clinical implications. Curr. Sex. Health Rep. 2016; 8(4): 213-21. https://dx.doi.org/10.1007/s11930-016-0091-0.
  20. Sánchez-Prieto M., Pingarrón C., Bergamaschi L., Bermúdez J.C., Subiris González J., Sánchez Sánchez R. et al. Prospective, multicenter, uncontrolled study on the effectiveness and safety of a hyaluronic acid water-based vaginal lubricant in alleviating vaginal dryness and dyspareunia. Gynecol. Endocrinol. 2024; 40(1): 2317268. https://dx.doi.org/10.1080/09513590.2024.2317268.
  21. Pérez-López F.R., Phillips N., Vieira-Baptista P., Cohen-Sacher B., Fialho S.C.A.V., Stockdale C.K. Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease. Gynecol. Endocrinol. 2021; 37(8): 746-52. https://dx.doi.org/10.1080/09513590.2021.1943346.
  22. Аполихина И.А., Тетерина Т.А., Тарнаева Л.А., Бартус К.А.Х. Женское и мужское здоровье сквозь призму рекомендаций Международной федерации гинекологии и акушерства 2023. Новый взгляд на микробиом и интимную гигиену. Акушерство и гинекология. 2023; 12: 158-66. [Apolikhina I.A., Teterina T.A., Tarnaeva L.A., Bartous K.A.H. Women's and men's health through the prism of the International Federation of Gynaecology and Obstetrics 2023 recommendations. A new insight into the microbiome and intimate hygiene. Obstetrics and Gynecology. 2023; (12): 158-66. (in Russian)]. https://dx.doi.org/10.18565/aig.2023.290.
  23. Litwiniuk M., Krejner A., Speyrer M.S., Gauto A.R., Grzela T. Hyaluronic acid in inflammation and tissue regeneration. Wounds. 2016; 28(3): 78-88.
  24. Neuman M.G., Nanau R.M., Oruña-Sanchez L., Coto G. Hyaluronic acid and wound healing. J. Pharm. Pharm. Sci. 2015; 18(1): 53-60. https://dx.doi.org/10.18433/j3k89d.
  25. Pitsouni E., Grigoriadis T., Douskos A., Kyriakidou M., Falagas M.E., Athanasiou S. Efficacy of vaginal therapies alternative to vaginal estrogens on sexual function and orgasm of menopausal women: A systematic review and meta-analysis of randomized controlled trials. Eur. J. Obstet. Gynecol. Reprod. Biol. 2018; 229: 45-56. https://dx.doi.org/10.1016/j.ejogrb.2018.08.008.
  26. Albalawi N.S., Almohammadi M.A., Albalawi A.R. Comparison of the efficacy of vaginal hyaluronic acid to estrogen for the treatment of vaginal atrophy in postmenopausal women: a systematic review. Cureus. 2023; 15(8): e44191 https://dx.doi.org/10.7759/cureus.44191.
  27. Nappi R.E., Kotek M., Breštánský A., Giordan N, Beriotto I., Tramentozzi E. Treatment of vulvo-vaginal atrophy with hyaluronate-based gel: a randomized controlled study. Minerva Obstet. Gynecol. 2022; 74(6): 480-8. https://dx.doi.org/10.23736/S2724-606X.21.04841-7.
  28. Nappi R.E., Martella S., Albani F., Cassani C., Martini E., Landoni F. Hyaluronic acid: a valid therapeutic option for early management of genitourinary syndrome of menopause in cancer survivors? Healthcare (Basel). 2022; 10(8): 1528. https://dx.doi.org/10.3390/healthcare10081528.
  29. UNFPA. Safe lubricants for all. Procurement specifications for lubricants used with male and female condoms. May 2022. https://www.unfpa.org/sites/default/files/pub-pdf/UNFPA_Lubricants%20Specs_web%20v2.pdf
  30. Łaniewski P., Owen K.A., Khnanisho M., Brotman R.M., Herbst-Kralovetz M.M. Clinical and personal lubricants impact the growth of vaginal lactobacillus species and colonization of vaginal epithelial cells: an in vitro study. Sex. Transm. Dis. 2021; 48(1): 63-70. https://dx.doi.org/10.1097/OLQ.0000000000001272.
  31. Духанин А.С., Семиошина О.Е. Рациональный выбор вагинального препарата: роль лекарственной формы. РМЖ. Мать и дитя. 2019; 2(4): 314-20. [Dukhanin A.S., Semioshina O.E. Rational choice of vaginal drug formulation. Russian Journal of Woman and Child Health. 2019; 2(4): 314-20. (in Russian)].
  32. Инструкция по применению медицинского изделия «Суппозитории вагинальные «Мойстана®», регистрационный номер медицинского изделия: РЗН 2023/21844. Доступно по: https://roszdravnadzor.gov.ru/services/misearch [Instructions for use of the medical device "Moystana vaginal suppositories", registration number of the medical device: RZN 2023/21844. Available at: https://roszdravnadzor.gov.ru/services/misearch (in Russian)].
  33. Bartels D.A., Johnson R., Bayor M.T., Ainooson G.K., Ossei P.P.S., Etuaful R.K. et al. Formulation of suppositories of alum produced from bauxite waste in Ghana for the treatment of hemorrhoid. Scientific World Journal. 2021; 2021: 6667562. https://dx.doi.org/10.1155/2021/6667562.
  34. Skrzypulec-Plinta V., Debski R., Paszkowski T., Poreba R., Drosdzol-Cop A. The influence of vaginal non-hormonal therapy containing hyaluronic acid, glycogen and lactic acid on sexual life and vulvovaginal atrophy in postmenopausal women. Ginekologia i Poloznictwo. 2014; 31(1): 66-73.
  35. Dębski R., Paszkowski T., Pertyński T., Skrzypulec-Plinta V. Stanowisko Zespołu Ekspertów Polskiego Towarzystwa Menopauzy i Andropauzy na temat zastosowania wyrobu medycznego HydroVag® w leczeniu zmian atroficznych pochwy. Menopausal Review. 2013; 2(2): 101-4. https://dx.doi.org/10.5114/pm.2013.35062.
  36. Серов В.Н., Аполихина И.А., Потекаев Н.Н., Баранов И.И., Олина А.А., Зароченцева Н.В., Чернова Н.И., Юренева С.В., Пасман Н.М., Полуэктова Е.А., Рахматулина М.Р., Припутневич Т.В., Пустотина О.А., Доля О.В., Тетерина Т.А. Резолюция Совета экспертов в области акушерства-гинекологии, дерматовенерологии, гастроэнтерологии и микробиологии «Принципы интимной гигиены у здоровых женщин и при заболеваниях вульвы». Акушерство и гинекология. 2023; 8: 229-34. [Serov V.N., Apolikhina I.A., Potekaev N.N., Baranov I.I., Olyna A.A., Zarochentseva N.V., Chernova N.I., Yureneva S.V., Pasman N.M., Poluektova E.A., Rakhmatulina M.R., Priputnevich T.V., Pustotina O.A., Dolya O.V., Teterina T.A. Resolution of the Council of Experts in obstetrics-gynecology, dermatovenerology, gastroenterology and microbiology "Principles of intimate hygiene in healthy women and in vulvar diseases". Obstetrics and Gynecology. 2023; (8): 229-34. (in Russian)]. https://dx.doi.org/10.18565/aig.2023.8.229-234.

Received 01.08.2024

Accepted 20.08.2024

About the Authors

Nadezhda I. Chernova, Dr. Med. Sci., Head of the Department of Anogenital Dermatosis and Sexually Transmitted Infections, Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology, 127473 Russia, Moscow, Seleznevskaya str., 20, +7(916)692-83-35, d.chernova@mail.ru, https://orcid.org/0000-0002-4111-6670
Olga V. Dolya, Professor, Dr. Med. Sci., Deputy Director for Scientific Work, Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology,
127473, Russia, Moscow, Seleznevskaya str., 20, dolya.o@mosderm.ru, https://orcid.org/0000-0001-5019-4593
Natalya V. Frigo, Professor, Dr. Med. Sci., Head of the Department of Scientific and Applied Research Methods, Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology, 127473, Russia, Moscow, Seleznevskaya str., 20, frigo@cnikvi.ru, https://orcid.org/0000-0001-6231-971X
Irina S. Zadorozhnaya, PhD, Junior Researcher at the Department of Anogenital Dermatosis and Sexually Transmitted Infections, Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology, 127473, Russia, Moscow, Seleznevskaya str., 20, d.zadorozhnayais@mail.ru, https://orcid.org/0000-0001-7291-3149
Corresponding author: Nadezhda I. Chernova, d.chernova@mail.ru

Similar Articles

№9 / 2024
Chekalova M.A., Meshcheryakova L.A., Streltsova O.N., Cherkasov E.Yu., Berdnikov S.N., Torosyan I.V.
Rare ultrasound image of malignant trophoblastic tumor
№10 / 2023
Bakhova L.A., Shevlyukova T.P., Keln A.A., Shvedsky M.S., Mateykovich E.A., Nekrasova O.V., Shkuratova V.V., Karmaeva O.S.
BRCA-associated breast cancer during pregnancy
№6 / 2022
Chernyshova А.L., Коlomiets L.А., Ivanova T.V., Usynin E.A., Afanasyev S.G., Shpileva O.V., Dil O.S., Li A.A., Bochkov Yu.A., Devald E.V., Antipov V.A., Krasilnikov S.E.
The course and outcome of pregnancy in the presence of advanced cervical cancer
№9 / 2024
Meskikh E.V., Ashrafyan L.A.
Pathogenetic therapy of benign breast dysplasia
№6 / 2021
Shabalova O.V., Yureneva S.V., Ermakova E.I., Khokhlova S.V., Gardanova Zh.R., Yakushevskaya O.V.
Surgical menopause as a risk factor for the early development of comorbid conditions in reproductive-aged women
By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.